Screening experience and baseline characteristics in the West of Scotland coronary prevention study
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 76 (7), 485-491
- https://doi.org/10.1016/s0002-9149(99)80135-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Assessing possible hazards of reducing serum cholesterolBMJ, 1994
- Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factorsThe American Journal of Cardiology, 1993
- Pravastatin experience in elderly and non-elderly patientsAtherosclerosis, 1993
- A coronary primary prevention study of Scottish men aged 45?64 years: Trial designJournal of Clinical Epidemiology, 1992
- Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.BMJ, 1990
- Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.BMJ, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Are low cholesterol values associated with excess mortality?BMJ, 1985
- The coronary primary prevention trial: Design and implementationJournal of Chronic Diseases, 1979
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978